Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf(Hamilton General Hospital), Marc A. Pfeffer(Brigham and Women's Hospital), Karl Swedberg(Sahlgrenska University Hospital), Christopher B. Granger(Duke Medical Center), Peter Held(AstraZeneca (Sweden)), John J.V. McMurray(University of Glasgow), Eric L. Michelson(AstraZeneca (United Kingdom)), Bertil Olofsson(AstraZeneca (Sweden)), Jan Östergren(Karolinska University Hospital)
The Lancet
September 1, 2003
Cited by 2,975

Abstract


Related Papers

No related papers found

Powered by citation graph analysis